This paper is only available as a PDF. To read, Please Download here.
Abstract
- 1.1. The reasons for the decline in popularity of therapeutic pneumothorax such as its pleural complications and its effect on pulmonary function are discussed.
- 2.2. The need for re-evaluation of pneumothorax combined with chemotherapy is recognized but it must await reports of long-term results.
- 3.3. Pneumoperitoneum is replacing pneumothorax in popularity and is needed in anticipated or demonstrated chemotherapeutic failures, especially if thoracic surgery is not applicable.
- 4.4. The use of pneumoperitoneum early in the course of chemotherapy in the presence of cavitary disease is discussed.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The American Journal of SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Tuberculosis in New York City 1953.in: New York Tuberculosis & Health Assoc, New York1954: 18
- Pneumoperitoneum in the treatment of pulmonary tuberculosis.Am. Rev. Tuberc. 1948; 52: 433
- Artificial pneumothorax: a statistical analysis of 557 cases initiated 1930–1939 and followed in 1949. 1.Am. Rev. Tuberc. 1951; 64: 1
- The after-history of pulmonary tuberculosis. II. Thoracoplasty: ten-year follow-up.Am. Rev. Tuberc. 1954; 69: 930
- Transactions of the Thirteenth Conference on the Chemotherapy of Tuberculosis. Veterans Administration—Army—Navy, 1954
- The initial period of artificial pneumothorax.Dis. of Chest. 1953; 24: 245
- Artificial pneumothorax: a statistical analysis of 557 cases initiated 1930–1939 and followed in 1949. IV. Incidence, mortality, and factors associated with complicating tuberculous empyema.Am. Rev. Tuberc. 1951; 64: 127
- Complications of pneumoperitoneum therapy.Dis. of Chest. 1953; 24: 82
- Pneumoperitoneum in the treatment of pulmonary tuberculosis.Am. Rev. Tuberc. 1947; 50: 306
- Phrenic nerve interruption in the treatment of pulmonary tuberculosis. II. Complications and sequelae of phreniclasis.Am. Rev. Tuberc. 1949; 60: 168
- The use of pneumoperitoneum as an adjunct to the prolonged streptomycin-para-amino salicylic acid treatment of pulmonary tuberculosis.Am. Rev. Tuberc. 1954; 69: 963
- Results of addition of pneumoperitoneum to long-term chemotherapy.in: Transactions of the Thirteenth Conference on the Chemotherapy of Tuberculosis. Veterans Administration—Army—Navy, 1954
Article info
Identification
Copyright
© 1955 Published by Elsevier Inc.
